A recent mBio study aimed to ascertain the durability and effectiveness of immune responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in terms of spike-binding antibody titers.
Study: SARS-CoV-2 Spike-Binding Antibody Longevity and Protection…
Source: www.news-medical.net – Read more

